BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/12/2020 6:27:11 AM | Browse: 58 | Download: 36
Publication Name World Journal of Gastrointestinal Pathophysiology
Manuscript ID 53850
Country/Territory China
Received
2019-12-31 07:20
Peer-Review Started
2019-12-31 07:32
To Make the First Decision
2020-03-02 04:03
Return for Revision
2020-03-03 00:09
Revised
2020-03-05 03:54
Second Decision
2020-04-08 13:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-04-09 00:22
Articles in Press
2020-04-09 00:22
Publication Fee Transferred
Edit the Manuscript by Language Editor
2020-04-14 01:27
Typeset the Manuscript
2020-05-11 01:07
Publish the Manuscript Online
2020-05-12 03:08
ISSN 2150-5330 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Review
Article Title Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
Manuscript Source Invited Manuscript
All Author List Xiu-Li Chen, Jing-Wei Mao and Ying-De Wang
Funding Agency and Grant Number
Corresponding author Ying-De Wang, MD, Chief Physician, Professor, Department of Gastroenterology, the First Affiliated Hospital of Dalian Medical University, No. 222, Zhongshan Road, Xigang District, Dalian 116011, Liaoning Province, China. albertwyd@163.com
Keywords Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Granulocyte and monocyte apheresis; Therapy; Efficacy
Core Tip Conventional therapies for inflammatory bowel disease (IBD) patients including mesalazine, corticosteroids, and immunosuppressants have been used for decades with unsatisfactory outcomes either due to their ineffectiveness or side effects. Although the emerging biologic agents including anti-TNF mono-antibodies have revolutionized IBD treatment, severe opportunistic infections, primary or secondary loss of response and etc. are the major clinical concerns of clinicians and patients as well. In recent years, selective granulocyte and monocyte apheresis, as a therapeutic option for IBD patients, have been used in Japan, Europe, China and elsewhere for its advantages of satisfactory efficacy, and particularly high safety profile. It is hopeful that granulocyte and monocyte apheresis therapy will become an important, and yet promising therapeutic option for patients with IBD.
Publish Date 2020-05-12 03:08
Citation Chen XL, Mao JW, Wang YD. Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future. World J Gastrointest Pathophysiol 2020; 11(3): 43-56
Url https://www.wjgnet.com/2150-5330/full/v11/i3/43.htm
DOI https://dx.doi.org/10.4291/wjgp.v11.i3.43
Full Article (PDF) WJGP-11-43.pdf
Full Article (Word) WJGP-11-43.docx
Manuscript File 53850_Review-Filipodia.docx
Answering Reviewers 53850-Answering reviewers.pdf
Audio Core Tip 53850-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 53850-Conflict-of-interest statement.pdf
Copyright License Agreement 53850-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 53850-Language certificate.pdf
Peer-review Report 53850-Peer-review(s).pdf
Scientific Misconduct Check 53850-Scientific misconduct check.pdf
Scientific Editor Work List 53850-Scientific editor work list.pdf